Showing results (81-90 of 293) with videos related to
Sort By:
Pageof 30
Journal of Biological Response Modifiers|October 1, 1984
Suppression by tumor growth of T cell growth factor production in mouse lymphoid cell culturesE Kedar, A Katz-Gross, E Chriqui-Zeira, et al.Annals of Burns and Fire Disasters|October 13, 2011
Case report: cytomegalovirus primoinfection may be associated with severe outcome in burnsC Augris, M Benyamina, F Rozenberg, et al.Bulletin De L'Academie Nationale De Medecine|October 1, 1993
[Child victims of house fires in France. Mortality, morbidity, prevention]B Leveque, L Lareng, H Julien, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1982
Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF)E Kedar, B L Ikejiri, E Gorelik, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1994
Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in miceE Kedar, E Braun, Y Rutkowski, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 1, 1997
Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in miceE Kedar, O Palgi, G Golod, et al.Transplantation|May 1, 1991
A short human and mouse MLR assay utilizing lymphokine (IL-2, IL-3) secretion as an early activation eventA Bishara, E Kedar, B Leshem, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1994
Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomesE Kedar, Y Rutkowski, E Braun, et al.Bone Marrow Transplantation|March 1, 1988
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT)E Kedar, R Or, E Naparstek, et al.Journal of Immunological Methods|June 28, 1988
Typing of HLA class II and class I antigens using PHA-activated, IL-2-propagated T lymphocytesB Leshem, I Cohen, L Sherman, et al.Pageof 30